SRI Antikörper (AA 1-198)
-
- Target Alle SRI Antikörper anzeigen
- SRI (Sorcin (SRI))
-
Bindungsspezifität
- AA 1-198
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SRI Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human Sorcin protein (1-198AA)
- Isotyp
- IgG
- Top Product
- Discover our top product SRI Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: WB:1:200-1:1000, IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- SRI (Sorcin (SRI))
- Andere Bezeichnung
- SRI (SRI Produkte)
- Hintergrund
-
Background: Calcium-binding protein that modulates excitation-contraction coupling in the heart. Contributes to calcium homeostasis in the heart sarcoplasmic reticulum. Modulates the activity of RYR2 calcium channels.
Aliases: 22 kDa protein antibody, Calcium binding protein amplified in mutlidrug resistant cells antibody, CP 22 antibody, CP-22 antibody, CP22 antibody, SCN antibody, Sorcin (class 4 gene) antibody, Sorcin antibody, SORCN_HUMAN antibody, SRI antibody, V19 antibody
- UniProt
- P30626
- Pathways
- Transition Metal Ion Homeostasis, Maintenance of Protein Location, Negative Regulation of Transporter Activity
-